Viking Therapeutics (VKTX) Tops Q4 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• AMC Entertainment prices $200M stock offering to redeem senior notes
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M